Get started
Author

Toshihiko Fujii

Observed names: T Fujii, T. Fujii, TOSHIHIKO FUJII, Toshihiko FUJII, フジイ, トシヒコ
ORCID: 0009-0006-0866-6458
Observed ORCID: 0009-0006-0866-6458
OpenAlex ID: A5007750749
An anti–glypican 3/CD3 bispecific T cell–redirecting antibody for treatment of solid tumors
2017 · Takahiro Ishiguro, Yuji Sano, et al. · Science Translational Medicine · 208
Involvement of CYP2J2 and CYP4F12 in the Metabolism of Ebastine in Human Intestinal Microsomes
2002 · Takanori Hashizume, Susumu Imaoka, et al. · Journal of Pharmacology and Experimental Therapeutics · 159
Synthesis and biological activities of benzofuran antifungal agents targeting fungal N-myristoyltransferase
2003 · Miyako Masubuchi, Hirosato Ebiike, et al. · Bioorganic & Medicinal Chemistry · 125
Design and synthesis of novel benzofurans as a new class of antifungal agents targeting fungal N -myristoyltransferase. Part 1
2001 · Miyako Masubuchi, Ken-ichi Kawasaki, et al. · Bioorganic & Medicinal Chemistry Letters · 122
The Fibroblast Growth Factor Receptor Genetic Status as a Potential Predictor of the Sensitivity to CH5183284/Debio 1347, a Novel Selective FGFR Inhibitor
2014 · Yoshito Nakanishi, Nukinori Akiyama, et al. · Molecular Cancer Therapeutics · 121
Neuroimaging of histamine H1‐receptor occupancy in human brain by positron emission tomography (PET): A comparative study of ebastine, a second‐generation antihistamine, and (+)‐chlorpheniramine, a classical antihistamine
2001 · Masaaki Tagawa, Michiko Kano, et al. · British Journal of Clinical Pharmacology · 104
PDF
The Selective Class I PI3K Inhibitor CH5132799 Targets Human Cancers Harboring Oncogenic PIK3CA Mutations
2011 · Hiroshi Tanaka, Miyuki Yoshida, et al. · Clinical Cancer Research · 100
Design and synthesis of novel benzofurans as a new class of antifungal agents targeting fungal N-myristoyltransferase. Part 3
2003 · Ken-ichi Kawasaki, Miyako Masubuchi, et al. · Bioorganic & Medicinal Chemistry Letters · 99
Design and synthesis of novel benzofurans as a new class of antifungal agents targeting fungal N-myristoyltransferase. Part 2
2002 · Hirosato Ebiike, Miyako Masubuchi, et al. · Bioorganic & Medicinal Chemistry Letters · 81
Mechanism of Oncogenic Signal Activation by the Novel Fusion Kinase FGFR3–BAIAP2L1
2015 · Yoshito Nakanishi, Nukinori Akiyama, et al. · Molecular Cancer Therapeutics · 67
PDF
cDNA Cloning and Expression of a Novel Cytochrome P450 (CYP4F12) from Human Small Intestine
2001 · Takanori Hashizume, Susumu Imaoka, et al. · Biochemical and Biophysical Research Communications · 67
Absorption, distribution and excretion of 3-(sulfamoyl[14C]methyl)-1,2-benziosoxazole (AD-810) in Rats, Dogs and Monkeys and of AD-810 in Men.
1983 · K Matsumoto, H Miyazaki, et al. · PubMed · 62
YES1 Is a Targetable Oncogene in Cancers Harboring YES1 Gene Amplification
2019 · Natsuki Hamanaka, Yoshito Nakanishi, et al. · Cancer Research · 58
Differential cognitive effects of ebastine and (+)‐chlorpheniramine in healthy subjects: Correlation between cognitive impairment and plasma drug concentration
2002 · Masaaki Tagawa, Michiko Kano, et al. · British Journal of Clinical Pharmacology · 53
PDF
Pharmacokinetics of the H1-receptor antagonist ebastine and its active metabolite carebastine in healthy subjects.
1994 · T Yamaguchi, T Hashizume, et al. · PubMed · 47
Hepatocyte Nuclear Factor-1α Is a Causal Factor Responsible for Interindividual Differences in the Expression of UDP-Glucuronosyltransferase 2B7 mRNA in Human Livers
2002 · Kenji Toide, Yoshiki Takahashi, et al. · Drug Metabolism and Disposition · 45
N-Dealkylation and hydroxylation of ebastine by human liver cytochrome P450.
1998 · T Hashizume, M Mise, et al. · PubMed · 44
Polymorphic Expression of Cyp1a2 Leading to Interindividual Variability in Metabolism of a Novel Benzodiazepine Receptor Partial Inverse Agonist in Dogs
2004 · Masashi Mise, Seiji Yadera, et al. · Drug Metabolism and Disposition · 42
In vitro activity of isavuconazole against 140 reference fungal strains and 165 clinically isolated yeasts from Japan
2010 · Toshikazu Yamazaki, Yukiko Inagaki, et al. · International Journal of Antimicrobial Agents · 41
Identification of non-functional allelic variant of CYP1A2 in dogs
2004 · Masashi Mise, Takanori Hashizume, et al. · Pharmacogenetics · 37
Enhanced antitumor activity of erlotinib in combination with the H sp90 inhibitor CH 5164840 against non‐small‐cell lung cancer
2013 · Naomi Ono, Toshikazu Yamazaki, et al. · Cancer Science · 34
Uridine diphosphate sugar-selective conjugation of an aldose reductase inhibitor (AS-3201) by UDP-glucuronosyltransferase 2B subfamily in human liver microsomes
2004 · Kenji Toide, Yoshiaki Terauchi, et al. · Biochemical Pharmacology · 33
A new methionine antagonist that has antifungal activity: Mode of action.
1994 · YUHKO AOKI, MASUMI KONDOH, et al. · The Journal of Antibiotics · 32
PDF
Disposition and metabolism of [3H]gliclazide in rats
1983 · Hisashi Miyazaki, Toshihiko Fujii, et al. · European Journal of Drug Metabolism and Pharmacokinetics · 30
Binding of sulfonamides to erythrocytes and their components.
1989 · Katashi MATSUMOTO, Hisashi MIYAZAKI, et al. · Chemical and Pharmaceutical Bulletin · 29
PDF
Works count: 162
Citation count: 2,211
H-index: 26
I10-index: 41
Year
Topic
Type